DuPont Company, Wilmington, DE

DuPont, "o-NITROTOLUENE", Material Safety Data Sheet, DuPont Company, Wilmington, DE (1985). 

Jeff Gunnulfsen, SOCMA, Washington, DC Julie Haack, University of Oregon, Eugene, OR Sharon L. Haynie, DuPont Company, Wilmington, DE Alan Hecht, U.S. Environmental Protection Agency, Washington, DC... 

Horacio E. Bergna, Lawrence E. Firment, and Dennis G. Swartzfager DuPont Company, Wilmington, DE 19880-0228... 

Subcontractors DuPont Company, Wilmington, DE Nuvera Fuel Cell, Cambridge, MA Northeastern University, Boston, MA... 

Many alterations in fatty acid composition were made. While these changes were driven by oil markets, they could impact full-fat and partially defatted soy protein products. These modifications include low-linolenic acid for enhanced oxidative stability, high-oleic acid, low-saturates, and high-saturates. Many of these traits are being marketed by Pioneer a DuPont Company (Wilmington, DE), Monsanto (St. Louis, MO), and Asoyia (Winfield, lA). Because many protein products contain residual oil in varying contents, differences in fatty acid compositions of that fat can affect properties of protein products, particularly flavor. 

DuPont Central Research and DuPont Chemicals DuPont Company Wilmington, DE 19880-0304... 

Favero, M.S., Biological hazards in the laboratory, in Proceedings of Institute on Critical Issues in Health Laboratory Practice, Richardson, J.W., Sdioenfeld, E., Tullis, J.W., and Wagna, W.W., Eds., The DuPont Company, Wilmington, DE, 1986, 1. 

Keating, J.T. (1997) Effect of Impurities on Membrane for Chloralkali Production. E.I. DuPont de Nemours and Company, Wilmington, DE, USA. 

DPC 961 (134, Scheme 2.21) has shown activity against wild-type HIV-1 and various non-nucleoside reverse transcriptase inhibitor-resistant HIV strains, and with greater potency than the structurally related efavirenz (Sustiva Bristol-Myers Squibb), an approved drug for HIV treat-ment. ° To facilitate the development of DPC 961, researchers at DuPont Pharmaceuticals Company (Wilmington, DE) developed an asymmetric conjugate addition strategy to introduce the trifluoromethyl amine stereocenter. As depicted in Scheme 2.21, treatment of the known aniline 128 ° with two equivalents of (R)-(-l-)-a-methylbenzyl isocyanate 129 afforded the hemiami-nal 130, which was subsequently converted into the 2(3//)-quinazolinone 131 by reaction with thionyl chloride and triethylamine. Reaction of the quinazolinone 131 with excess cyclopropylacetylene magnesium chloride 132 provided the dihydroquinazolinone 133 in 86% yield and 92% diastereomeric excess. Conversion of the dihydroquinazolinone 133 into DPC 961 134 involved treatment with tri-fluoroacetic acid or warm formic acid. Overall, this process provided 16 kg of DPC 961 134 in >55% overall yield from aniline 128. 

Contribution No. 285 from the Chemical Department, Experimental Station, E. I. duPont de Nemours and Company, Wilmington, Delaware. 

DuPont, 19 Hydrofluoric Acid, Anhydrous - Technical, Properties, Uses, Storage and Ha ing, undated bulletin, E.I. duPont de Nemours Company, Wilmington, DL,. 

Figure 11-24. General replacement guide for refrigerant phaseout Suva Refrigerants. (Used by permission DuPont Company, Fluoroproducts, SUVA Refrigerants, Wilmington, DE.)...

Mel-Temp Millipore Swagelok Teflon Laboratory Devices, Cambridge, Massachusetts Millipore Corporation, Bedford, Massachusetts Crawford Fitting Company, Solon, Ohio E.I. DuPont de Nemours Company, Wilmington, Delaware... 

The DuPont Pharmaceuticals Company, Department of Chemical Physical Sciences, Experimental Station, P.O. Box 80500, Wilmington, DE, USA 19880-0500... 

Hood DB Toxicity of n-Propyl Nitrate and Isopropyl Nitrate, Haskell Laboratory for Tjxicology and Industrial Medicine, Report No 21-53. Wilmington, DE, El duPont de Nemours and Company, 1953... 

---